Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

NCT00100659

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

The Children's Hospital Denver, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View Trial Details

Completed

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

NCT01429792

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Haemek Hospital; Gastroenterology Afula, Israel

Clalit City Ashdod MC; Liver Clinic Ashdod, Israel

Barzilai MC; Gastroenterology Ashkelon, Israel

Batyamon; Liver Unit Bat Yam, Israel

View all 26 locations

View Trial Details

Completed

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

NCT01370642

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

NCT01405560

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

NCT03710252

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Hepatitis C Alcohol Reduction Treatment

NCT02176980

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

NCT01405937

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

NCT02640547

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

NCT02833298

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin

NCT03686722

Conditions: Blood-Borne Infections, Communicable Diseases, Diabetes Mellitus, +15 more
Locations: Drug research centre Cairo, Egypt

View Trial Details